AC
BIOTW

Aristeia Capital’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Aristeia Capital’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-601,133
Closed -$37.4K – 537
2022
Q4 		$37.4K Hold
601,133
– – ﹤0.01% 374
2022
Q3 		$34K Hold
601,133
– – ﹤0.01% 505
2022
Q2 		$39K Sell
601,133
-458,971
-43% -$94.8K ﹤0.01% 552
2022
Q1 		$251K Sell
1,060,104
-400
-0% -$128 ﹤0.01% 432
2021
Q4 		$668K Buy
+1,060,504
New +$736K 0.01% 421

Aristeia Capital's BIOTW Position: Q1 2023 in Review

Aristeia Capital sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 601,133 shares — an estimated $37.4K sold.

Aristeia Capital first reported a position in BIOTW in Q4 2021 and held it in 5 quarters. The position peaked at $668K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

  • Aristeia Capital reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
  • Aristeia Capital sold 601,133 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $37.4K.
  • Aristeia Capital first reported a position in Biotech Acquisition Company Warrant in Q4 2021 and held it in 5 quarters.
  • Aristeia Capital's Biotech Acquisition Company Warrant position peaked at $668K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Aristeia Capital's 13F filing for Q1 2023, filed 16 May 2023.